Which hedge funds own AVBP? ARRIVENT BIOPHARMA INC, Q2 2026 13F holders
8 of the hedge funds tracked by WhaleCreep disclosed a position in AVBP (ARRIVENT BIOPHARMA INC) in their Q2 2026 13F filings, worth $233.8m in total. The largest holder by portfolio weight is Suvretta Capital Management at 3.3% of its book. 1 manager opened a new position this quarter: Brevan Howard Capital Management. 1 exited: Marshall Wace.
8tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold AVBP? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Suvretta Capital Management | Q2 2026 | 3.3% | $156.9m | 4,515,531 | 3% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $19.7m | 566,796 | -24% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $30.3m | 872,011 | 136% | added |
| Woodline Partners | Q2 2026 | 0.0% | $5.1m | 147,639 | 0% | held |
| Millennium Management | Q2 2026 | 0.0% | $15.2m | 438,664 | 3% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $306.5k | 8,823 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $809.0k | 23,287 | 5% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $5.4m | 156,742 | -6% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Marshall Wace | 0.0% | $811.3k |
How has hedge fund ownership of AVBP changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $233.8m |
| Q1 2026 | 8 | $145.7m |
| Q4 2025 | 3 | $89.9m |
| Q3 2025 | 2 | $73.8m |
| Q2 2025 | 2 | $77.5m |
| Q1 2025 | 3 | $46.2m |
| Q4 2024 | 2 | $63.7m |
| Q3 2024 | 2 | $46.2m |
| Q2 2024 | 2 | $33.6m |
| Q1 2024 | 4 | $32.9m |
Counts every tracked manager that disclosed AVBP in that quarter's filing, including managers that have since stopped filing.